CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.

N Chatzimanolis; Jörg Kraus; R Bauer; B Engelhardt; T Bregenzer; B S Kuehne; J Tofighi; C Laske; E Stolz; F Blaes; K Voigt; H Traupe; M Kaps; P Oschmann

doi:10.1111/j.1600-0404.2004.00346.x

CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.

N Chatzimanolis, Jörg Kraus^* (Co-author), R Bauer, B Engelhardt, T Bregenzer, B S Kuehne, J Tofighi, C Laske, E Stolz, F Blaes, K Voigt, H Traupe, M Kaps, P Oschmann

^*Corresponding author for this work

Research output: Contribution to journal › Original Article (Journal) › peer-review

6 Citations (Web of Science)

Original language	English
Pages (from-to)	377-385
Journal	ACTA NEUROLOGICA SCANDINAVICA
Volume	110
Issue number	6
DOIs	https://doi.org/10.1111/j.1600-0404.2004.00346.x
Publication status	Published - 2004

Keywords

T-CELL-ACTIVATION
INTERFERON-BETA
DISEASE-ACTIVITY
IN-VITRO
CEREBROSPINAL-FLUID
COUNTER-RECEPTOR
CONTROLLED TRIAL
SOLUBLE VCAM-1
BLOOD
MRI

Access to Document

10.1111/j.1600-0404.2004.00346.x

Cite this

Chatzimanolis, N., Kraus, J., Bauer, R., Engelhardt, B., Bregenzer, T., Kuehne, B. S., Tofighi, J., Laske, C., Stolz, E., Blaes, F., Voigt, K., Traupe, H., Kaps, M., & Oschmann, P. (2004). CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis. ACTA NEUROLOGICA SCANDINAVICA , 110(6), 377-385. https://doi.org/10.1111/j.1600-0404.2004.00346.x

Chatzimanolis, N ; Kraus, Jörg ; Bauer, R et al. / CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis. In: ACTA NEUROLOGICA SCANDINAVICA 2004 ; Vol. 110, No. 6. pp. 377-385.

@article{15a09328fdec4f0aa917e955c6095c33,

title = "CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.",

keywords = "T-CELL-ACTIVATION, INTERFERON-BETA, DISEASE-ACTIVITY, IN-VITRO, CEREBROSPINAL-FLUID, COUNTER-RECEPTOR, CONTROLLED TRIAL, SOLUBLE VCAM-1, BLOOD, MRI",

author = "N Chatzimanolis and J{\"o}rg Kraus and R Bauer and B Engelhardt and T Bregenzer and Kuehne, {B S} and J Tofighi and C Laske and E Stolz and F Blaes and K Voigt and H Traupe and M Kaps and P Oschmann",

year = "2004",

doi = "10.1111/j.1600-0404.2004.00346.x",

language = "English",

volume = "110",

pages = "377--385",

journal = "ACTA NEUROLOGICA SCANDINAVICA ",

issn = "0001-6314",

number = "6",

}

Chatzimanolis, N, Kraus, J, Bauer, R, Engelhardt, B, Bregenzer, T, Kuehne, BS, Tofighi, J, Laske, C, Stolz, E, Blaes, F, Voigt, K, Traupe, H, Kaps, M & Oschmann, P 2004, 'CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.', ACTA NEUROLOGICA SCANDINAVICA , vol. 110, no. 6, pp. 377-385. https://doi.org/10.1111/j.1600-0404.2004.00346.x

CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis. / Chatzimanolis, N; Kraus, Jörg (Co-author); Bauer, R et al.
In: ACTA NEUROLOGICA SCANDINAVICA , Vol. 110, No. 6, 2004, p. 377-385.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.

AU - Chatzimanolis, N

AU - Kraus, Jörg

AU - Bauer, R

AU - Engelhardt, B

AU - Bregenzer, T

AU - Kuehne, B S

AU - Tofighi, J

AU - Laske, C

AU - Stolz, E

AU - Blaes, F

AU - Voigt, K

AU - Traupe, H

AU - Kaps, M

AU - Oschmann, P

PY - 2004

Y1 - 2004

KW - T-CELL-ACTIVATION

KW - INTERFERON-BETA

KW - DISEASE-ACTIVITY

KW - IN-VITRO

KW - CEREBROSPINAL-FLUID

KW - COUNTER-RECEPTOR

KW - CONTROLLED TRIAL

KW - SOLUBLE VCAM-1

KW - BLOOD

KW - MRI

U2 - 10.1111/j.1600-0404.2004.00346.x

DO - 10.1111/j.1600-0404.2004.00346.x

M3 - Original Article (Journal)

C2 - 15527450

SN - 0001-6314

VL - 110

SP - 377

EP - 385

JO - ACTA NEUROLOGICA SCANDINAVICA

JF - ACTA NEUROLOGICA SCANDINAVICA

IS - 6

ER -

Chatzimanolis N, Kraus J, Bauer R, Engelhardt B, Bregenzer T, Kuehne BS et al. CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis. ACTA NEUROLOGICA SCANDINAVICA . 2004;110(6):377-385. doi: 10.1111/j.1600-0404.2004.00346.x